Stock Analysis on Net
Stock Analysis on Net

DexCom Inc. (NASDAQ:DXCM)

This company has been moved to the archive! The financial data has not been updated since October 26, 2023.

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

DexCom Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in thousands

Microsoft Excel
Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Accounts payable and accrued liabilities 1,373,100 1,156,500 965,200 901,800 764,200 688,300 603,100 573,000 598,000 482,000 502,600 481,100 397,000 315,900 267,500 256,400 232,400 196,700 169,100 147,100 135,400 117,900 88,000
Accrued payroll and related expenses 151,300 108,600 94,800 134,300 112,700 94,800 84,700 125,200 115,300 98,100 81,400 114,300 92,100 67,400 59,000 88,500 70,900 73,900 51,300 72,400 55,000 46,100 34,200
Current portion of long-term senior convertible notes 124,200 773,800 773,200 772,600 — — — — — — — — — — — — — — — — — — —
Short-term operating lease liabilities 21,000 21,800 22,200 20,500 20,900 21,200 20,900 20,500 19,300 18,800 18,200 16,500 15,800 15,100 14,500 13,600 14,800 14,100 12,300 — — — —
Deferred revenue 9,000 9,000 9,600 10,100 2,700 2,700 2,700 2,100 2,300 1,800 1,900 2,200 1,500 1,700 1,800 1,700 4,300 3,500 2,700 2,900 3,500 6,800 2,900
Current liabilities 1,678,600 2,069,700 1,865,000 1,839,300 900,500 807,000 711,400 720,800 734,900 600,700 604,100 614,100 506,400 400,100 342,800 360,200 322,400 288,200 235,400 222,400 193,900 170,800 125,100
Long-term senior convertible notes 2,432,400 2,430,600 1,198,500 1,197,700 1,968,800 1,967,300 1,965,900 1,702,700 1,703,500 1,710,700 1,688,800 1,667,200 1,645,800 1,658,800 1,072,400 1,059,700 1,047,100 1,034,700 1,022,400 1,010,300 338,800 335,000 331,300
Long-term operating lease liabilities 83,400 86,900 89,700 94,600 82,100 87,700 93,300 98,600 102,900 107,100 111,300 101,800 103,200 73,700 77,300 72,400 34,300 37,200 29,500 — — — —
Other long-term liabilities 133,900 133,100 129,700 128,300 123,300 99,500 97,100 90,000 98,500 87,700 82,400 80,900 78,500 35,300 20,900 20,100 17,600 17,500 18,100 20,000 19,400 19,600 18,700
Long-term liabilities 2,649,700 2,650,600 1,417,900 1,420,600 2,174,200 2,154,500 2,156,300 1,891,300 1,904,900 1,905,500 1,882,500 1,849,900 1,827,500 1,767,800 1,170,600 1,152,200 1,099,000 1,089,400 1,070,000 1,030,300 358,200 354,600 350,000
Total liabilities 4,328,300 4,720,300 3,282,900 3,259,900 3,074,700 2,961,500 2,867,700 2,612,100 2,639,800 2,506,200 2,486,600 2,464,000 2,333,900 2,167,900 1,513,400 1,512,400 1,421,400 1,377,600 1,305,400 1,252,700 552,100 525,400 475,100
Preferred stock, $0.001 par value; no shares issued and outstanding — — — — — — — — — — — — — — — — — — — — — — —
Common stock, $0.001 par value 400 400 400 400 400 400 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Additional paid-in capital 3,618,000 2,269,000 2,305,600 2,258,100 2,072,100 2,028,900 1,996,600 2,504,500 2,322,100 2,193,600 2,162,000 2,125,300 2,153,700 2,079,800 1,706,500 1,675,900 1,651,600 1,620,400 1,590,600 1,560,600 1,181,600 1,149,100 1,122,500
Accumulated other comprehensive income (loss) (35,600) (29,300) (6,500) (11,600) (41,100) (23,000) (6,100) 500 1,400 2,800 2,900 3,200 2,800 3,500 3,700 2,300 1,000 2,000 1,600 1,500 (300) (1,300) (4,900)
Retained earnings (accumulated deficit) 765,100 644,400 528,500 479,900 388,100 286,900 236,000 (47,400) (28,000) (98,900) (161,800) (202,100) (557,300) (629,500) (675,800) (695,700) (788,400) (834,200) (823,700) (798,900) (619,200) (665,800) (696,000)
Treasury stock, at cost (2,080,000) (784,100) (595,000) (595,000) (595,000) (37,300) (37,300) (206,200) (159,500) (100,000) (100,000) (100,000) (100,000) (100,000) (100,000) (100,000) (100,000) (100,000) (100,000) (100,000) — — —
Stockholders’ equity 2,267,900 2,100,400 2,233,000 2,131,800 1,824,500 2,255,900 2,189,300 2,251,500 2,136,100 1,997,600 1,903,200 1,826,500 1,499,300 1,353,900 934,500 882,600 764,300 688,300 668,600 663,300 562,200 482,100 421,700
Total liabilities and stockholders’ equity 6,596,200 6,820,700 5,515,900 5,391,700 4,899,200 5,217,400 5,057,000 4,863,600 4,775,900 4,503,800 4,389,800 4,290,500 3,833,200 3,521,800 2,447,900 2,395,000 2,185,700 2,065,900 1,974,000 1,916,000 1,114,300 1,007,500 896,800

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. DexCom Inc. current liabilities increased from Q1 2023 to Q2 2023 but then decreased significantly from Q2 2023 to Q3 2023.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. DexCom Inc. long-term liabilities increased from Q1 2023 to Q2 2023 but then slightly decreased from Q2 2023 to Q3 2023.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. DexCom Inc. total liabilities increased from Q1 2023 to Q2 2023 but then slightly decreased from Q2 2023 to Q3 2023.
Stockholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. DexCom Inc. stockholders’ equity decreased from Q1 2023 to Q2 2023 but then increased from Q2 2023 to Q3 2023 exceeding Q1 2023 level.